Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.08.27.609963

Cargo quantification of functionalized DNA origami for therapeutic application

Abstract

In recent years, notable advances in nanotechnology-based drug delivery have emerged. A particularly promising platform in this field is DNA origami-based nanoparticles, which offer highly programmable surfaces, providing precise control over the nanoscale spacing and stoichiometry of various cargo. These versatile particles are finding diverse applications ranging from basic molecular biology to diagnostics and therapeutics. This growing interest creates the need for effective methods to quantify cargo on DNA origami nanoparticles. Our study consolidates several previously validated methods focusing on gel-based and fluorescence-based techniques, including multiplexed quantification of protein, peptide, and nucleic acid cargo on these nanoparticles. This work may serve as a valuable resource for groups researchers keen on utilizing DNA origami-based nanoparticles in therapeutic applications. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=135 SRC="FIGDIR/small/609963v1_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@1703793org.highwire.dtl.DTLVardef@50b368org.highwire.dtl.DTLVardef@327a3corg.highwire.dtl.DTLVardef@1f732b0_HPS_FORMAT_FIGEXP M_FIG C_FIG

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Young, O., Dembele, H., Rajwar, A., Kwon, I. C., Ryu, J. H., Shih, W., Zeng, Y.. 2024-08-27. Cargo quantification of functionalized DNA origami for therapeutic application. https://doi.org/10.1101/2024.08.27.609963

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Minimal, synthetic arginine deiminase pathway provides full ATP demand for cellular growth

Bottom-up construction of synthetic cells requires a simple, yet robust ATP-generating system. The arginine deiminase (ADI) pathway offers a minimal, enzyme-based alternative to more complex ATP-producing systems such as glycolytic routes, respiratory chains or photosystems. Here, we implement the ADI pathway in Escherichia coli and test its capacity to fully replace native ATP generation. First, we designed and tested synthetic ADI operons through combinatorial library screening and selected high-performing variants. Using the best performing-ADI variant, we progressively reduced the cells dependence on native ATP generation while increasing selection for ADI-dependent growth through targeted knockout strains and growth conditions, followed by adaptive laboratory evolution. This resulted in a strain in which the ADI pathway sustained growth in minimal medium at a doubling time of 21 hours, serving as the sole source of ATP. Whole-genome sequencing of evolved strains revealed that this transition required loss-of-function mutations in the native respiratory chain. These findings demonstrate that the ATP supply of a cell can be fully supported by the ADI pathway, which has not been demonstrated in nature. Moreover, the ability of the pathway to sustain growth with a relatively high growth rate highlights its potential to fully power synthetic cells and support other biotechnological applications.

synthetic biology↗

Scalable recorders of cellular calcium dynamics and molecular interactions across time

Cellular processes are mediated by dynamic biochemical events in their native context, including changes in intracellular ion concentrations and transient interactions between molecules. Studying these processes across large cell populations requires recording their dynamics across time in single cells, simultaneously and at scale. Here, we introduce split-1POK, a split protein tape monomer whose two halves reconstitute when the domains fused to them interact. The reconstituted monomer is incorporated into the protein tape as it elongates across time in live cells, enabling scalable, spatiotemporally resolved endpoint readout under conventional light microscopy. Split-1POK provides a programmable scaffold for new recorders in the CytoSense family, our previously introduced framework (ref. 1) in which the same cytosol-localized monomer senses cellular activity and writes it along protein tape recorders. Unlike transcription-based activity recorders, which encode the signal through new gene expression, CytoSense recorders act on monomers post-synthesis, so the activity signal is sensed and written directly in the cytosol without passing through transcription- or translation-associated cascades. Fusing calmodulin and its binding peptide to split-1POK, we built TCaMP (Tape monomer-CalModulin-Peptide), a genetically encoded calcium recorder (GECR) that measures calcium dynamics on a single, analog intensity scale along a continuous time axis, providing quantitative comparison of calcium levels over time within the same cell. In cultured human cells, TCaMP records transient calcium dynamics from transmembrane entry, receptor activation, and intracellular store release, detecting stimulations as brief as ten minutes. With hour-scale kinetics over days, TCaMP complements fluorescent calcium indicators by trading sub-second temporal resolution for scalable, long-term recording. Fusing conditional dimerization pairs to split-1POK yields recorders of molecular interaction histories in response to external stimuli. Split-1POK thus brings scalable, spatiotemporally resolved recording to intracellular calcium dynamics and molecular interactions across time.

synthetic biology↗

Antibody design across observed and forecasted antigenic evolution

The therapeutic efficacy of antibodies is often limited by the evolution of their targets. Designing or eliciting antibodies that withstand such evolution is challenging as their binding interfaces must accommodate antigenic variation. Here, we introduce Germinal Multi, a computational framework for de novo antibody design and rescue that jointly optimizes a single paratope against multiple antigenic variants. We applied Germinal Multi to cancer and viral antigens, targeting both observed antigenic variation and prospective antibody escape. Multi-target optimization yielded antibodies that bound resistance-associated EGFR variants or that neutralized antigenically distinct historical SARS-CoV-2 variants, with recognition extending to variants withheld from the design process. Beyond acting on observed evolution, we redesigned the broadly neutralizing antibody BD55-1205 to restore neutralization of a prospective escape variant engineered with guidance from an evolutionary forecasting model, while preserving activity against the parental variant. Successful candidates were identified after screening tens of designs per campaign. Together, these results establish multi-target computational design as a strategy for generating antibody breadth across observed antigenic variation and demonstrate the potential of evolutionary forecasting to guide antibody redesign against prospective escape.

synthetic biology↗